Edit |   |
---|---|
Antigenic Specificity | CD2 |
Clone | monoclonal |
Host Species | Recombinant Rat |
Reactive Species | human |
Isotype | n/a |
Format | unconjugated |
Size | n/a |
Concentration | n/a |
Applications | ELISA, IP, FC, FuncS, Neut, IF, ICC, |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD2 Recombinant Antibody (Siplizumab). Recombinant monoclonal antibody to CD2. Siplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1, kappa directed to CD2. The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease. |
Immunogen | Human CD2 recombinant protein |
Other Names | Siplizumab;288392-69-8;MEDI-507;CD2;CD2 molecule;CD2 antigen (p50), sheep red blood cell receptor , SRBC;T-cell surface antigen CD2;LFA-3 receptor;rosette receptor;erythrocyte receptor;lymphocyte-function antigen-2;T-cell surface antigen T11/Leu-5;CD2 ant |
Gene, Accession # | UniProt: P06729 |
Catalog # | TAB-104 |
Price | please inquire |
Order / More Info | CD2 Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |